Long-term cyclosporin A pharmacokinetic profiles in pediatric renal transplant recipients

Transpl Int. 1996;9(6):546-50. doi: 10.1007/BF00335553.

Abstract

To study the long-term effect of cyclosporin A (CyA), 94 6-h and 29 12-h pharmacokinetic profiles were evaluated in 32 children at least 1 year after renal transplantation. Children weighing less than 25 kg needed significantly higher doses of CyA than those weighing more than 25 kg (9.8 vs 5.3 mg/kg per day; P < 0.001) to achieve similar trough levels (TL). The average dose of CyA required to achieve the target TL declined gradually with time after transplantation. The average area under the curve over 6 h (AUC/6) correlated strongly with the AUC/12 (r = 0.967; P < 0.001). The AUC/6 of patients with biopsy-proven CyA toxicity was significantly higher than for those without toxicity (Mann-Whitney U-test P < 0.05) despite similar TL. We conclude that AUC monitoring for 6 h provides valuable information not only on TL but also on the absorption and elimination characteristics of CyA as well as on the potential for CyA toxicity.

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Cyclosporine / administration & dosage
  • Cyclosporine / adverse effects
  • Cyclosporine / pharmacokinetics*
  • Dose-Response Relationship, Drug
  • Female
  • Graft Rejection / prevention & control*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / pharmacokinetics*
  • Infant
  • Kidney Transplantation*
  • Male
  • Time Factors

Substances

  • Immunosuppressive Agents
  • Cyclosporine